MRI in the early identification and classification of high-risk atherosclerotic carotid plaques

Imaging in Medicine

Volumn 2, Issue 1, 2010, Pages 63-75

  Hatsukami, Thomas S ^a   Yuan, Chun ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

carotid atherosclerosis; early stage atherosclerosis; high risk plaque; MRI; stroke; vulnerable plaque

Indexed keywords

LIPID;

ATHEROSCLEROTIC PLAQUE; B SCAN; BLOOD VESSEL WALL; CAROTID ARTERY OBSTRUCTION; CAROTID ATHEROSCLEROSIS; CLINICAL STUDY; CONSENSUS; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; HIGH RISK POPULATION; HISTOLOGY; HUMAN; HYPOTHESIS; IN VIVO STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RELIABILITY; REVIEW; VASCULITIS;

EID: 77954117699     PISSN: 17555191     EISSN: 17555205     Source Type: Journal    
DOI: 10.2217/iim.09.33     Document Type: Review

References (101)

1. Lloyd-Jones D, Adams R, Carnethon M et al.: Heart disease and stroke statistics-2009 update: a report from the American Heart Association statistics committee and stroke statistics subcommittee. Circulation 119(3), e21-e181 (2009).
2. Brown Dl, Boden-Albala B, Langa KM et al.: Projected costs of ischemic stroke in the United States. Neurology 67(8), 1390-1395 (2006)
3. NASCET: Benefcial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N. Engl. J. Med. 325(7), 445-453 (1991)
4. ECST: MRC European carotid surgery trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. Lancet 337(8752), 1235-1243 (1991).
5. Mayberg MR, Wilson SE, Yatsu F et al.: Carotid endarterectomy and prevention of cerebral ischemia in symptomatic carotid stenosis. Veterans Affairs Cooperative Studies Program 309 Trialist Group. JAMA 266(23), 3289-3294 (1991).
6. Eliasziw M, Streifer JY, Fox AJ, Hachinski VC, Ferguson GG, Barnett HJ: Signifcance of plaque ulceration in symptomatic patients with high-grade carotid stenosis. Stroke 25(2), 304-308 (1994).
7. Rothwell PM, Gutnikov SA, Warlow CP: Reana lysis of the fnal results of the European Carotid Surgery Trial. Stroke 34(2), 514-523 (2003).
8. Barnett HJ, Taylor DW, Eliasziw M et al.: Beneft of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N. Engl. J. Med. 339(20), 1415-1425 (1998).
9. Wasserman BA, Wityk RJ, Trout HH 3rd, Virmani R: Low-grade carotid stenosis: looking beyond the lumen with MRI. Stroke 36(11), 2504-2513 (2005).
10. Babiarz LS, Astor B, Mohamed MA, Wasserman BA: Comparison of gadolinium-enhanced cardiovascular magnetic resonance angiography with high-resolution black blood cardiovascular magnetic resonance for assessing carotid artery stenosis. J. Cardiovasc. Magn. Reson. 9(1), 63-70 (2007).
11. Yoshida K, Endo H, Sadamasa N et al.: Evaluation of carotid artery atherosclerotic plaque distribution by using long-axis high-resolution black-blood magnetic resonance imaging. J. Neurosurg. 109(6), 1042-1048 (2008).
12. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ: Compensatory enlargement of human atherosclerotic coronary arteries. N. Engl. J. Med. 316(22), 1371-1375 (1987). (Pubitemid 17079680)
13. Carr S, Farb A, Pearce WH, Virmani R, Yao JST: Atherosclerotic plaque rupture in symptomatic carotid artery stenosis. J. Vasc. Surg. 23, 755-766 (1996).
14. Carr SC, Farb A, Pearce WH, Virmani R, Yao JST: Activated infammatory cells are associated with plaque rupture in carotid artery stenosis. Surgery 122(4), 757-763; discussion 763-1754 (1997).
15. Bassiouny HS, Sakaguchi Y, Mikucki SA et al.: Juxtalumenal location of plaque necrosis and neoformation in symptomatic carotid stenosis. J. Vasc. Surg. 26(4), 585-594 (1997).
16. Mccarthy MJ, Loftus IM, Thompson MM et al.: Angiogenesis and the atherosclerotic carotid plaque: an association between symptomatology and plaque morphology. J. Vasc. Surg. 30(2), 261-268. (1999).
17. Mofdi R, Crotty TB, Mccarthy P, Sheehan SJ, Mehigan D, Keaveny TV: Association between plaque instability, angiogenesis and symptomatic carotid occlusive disease. Br. J. Surg. 88(7), 945-950 (2001).
18. Redgrave JN, Lovett JK, Gallagher PJ, Rothwell PM: Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford Plaque Study. Circulation 113(19), 2320-2328 (2006).
19. Spagnoli LG, Mauriello A, Sangiorgi G et al.: Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke. JAMA 292(15), 1845-1852 (2004).
20. Johnson JM, Kennelly MM, Decesare D, Morgan S, Sparrow A: Natural history of asymptomatic carotid plaque. Arch. Surg. 120(9), 1010-1012 (1985).
21. O'Holleran LW, Kennelly MM, McClurken M, Johnson JM: Natural history of asymptomatic carotid plaque. Five year follow-up study. Am. J. Surg. 154(6), 659-662 (1987).
22. Sterpetti AV, Hunter WJ, Schultz RD: Importance of ulceration of carotid plaque in determining symptoms of cerebral ischemia. J. Cardiovasc. Surg. 32(2), 154-158 (1991).
23. Sterpetti AV, Schultz RD, Feldhaus RJ et al.: Ultrasonographic features of carotid plaque and the risk of subsequent neurologic defcits. Surgery 104(4), 652-660 (1988).
24. Langsfeld M, Gray WAC, Lusby RJ: The role of plaque morphology and diameter reduction in the development of new symptoms in asymptomatic carotid arteries. J. Vasc. Surg. 9(4), 548-557 (1989).
25. Belcaro G, Laurora G, Cesarone MR et al.: Ultrasonic classifcation of carotid plaques causing less than 60% stenosis according to ultrasound morphology and events. J. Cardiovasc. Surg. 34(4), 287-294 (1993).
26. Bock RW, Gray-Weale AC, Mock PA et al.: The natural history of asymptomatic carotid artery disease. J. Vasc. Surg. 17(1), 160-169 (1993).
27. Manolio TA, Burke GL, O'Leary DH et al.: Relationships of cerebral MRI fndings to ultrasonographic carotid atherosclerosis in older adults: the Cardiovascular Health Study. CHS Collaborative Research Group. Arterioscler. Thromb. Vasc. Biol. 19(2), 356-365 (1999).
28. Insana MF, Hall TJ, Fishback JL: Identifying acoustic scattering sources in normal renal parenchyma from the anisotropy in acoustic properties. Ultrasound Med. Biol. 17(6), 613-626 (1991).
29. Rubin JM, Carson PL, Meyer CR: Anisotropic ultrasonic backscatter from the renal cortex. Ultrasound Med. Biol. 14(6), 507-511 (1988).
30. Hatsukami TS, Thackray BD, Primozich JF et al.: Echolucent regions in carotid plaque: preliminary ana lysis comparing three-dimensional histologic reconstructions to sonographic fndings. Ultrasound Med. Biol. 20(8), 743-749 (1994).
31. Widder B, Paulat K, Hackspacher J et al.: Morphological characterization of carotid artery stenoses by ultrasound duplex scanning. Ultrasound Med. Biol. 16(4), 349-354 (1990). (Pubitemid 20241978)
32. Feeley TM, Leen EJ, Colgan MP, Moore DJ, Hourihane DO, Shanik GD: Histologic characteristics of carotid artery plaque. J. Vasc. Surg. 13(5), 719-724 (1991).
33. O'Leary DH, Holen J, Ricotta JJ, Roe S, Schenk EA: Carotid bifurcation disease: prediction of ulceration with B-mode US. Radiology 162(2), 523-525 (1987).
34. O'Leary DH, Bryan FA, Goodison MW et al.: Measurement variability of carotid atherosclerosis: real-time (B-mode) ultrasonography and angiography. Stroke 18(6), 1011-1017 (1987).
35. Serfaty JM, Nonent M, Nighoghossian N et al.: Plaque density on CT, a potential marker of ischemic stroke. Neurology 66(1), 118-120 (2006).
36. Nandalur KR, Baskurt E, Hagspiel KD et al.: Carotid artery calcifcation on CT may independently predict stroke risk. AJR Am. J. Roentgenol. 186(2), 547-552 (2006).
37. Miralles M, Merino J, Busto M, Perich X, Barranco C, Vidal-Barraquer F: Quantifcation and characterization of carotid calcium with multi-detector CT-angiography. Eur. J. Vasc. Endovasc. Surg. 32(5), 561-567 (2006).
38. Shaalan WE, Cheng H, Gewertz B et al.: Degree of carotid plaque calcifcation in relation to symptomatic outcome and plaque infammation. J. Vasc. Surg. 40(2), 262-269 (2004). (Pubitemid 39055888)
39. De Weert TT, Ouhlous M, Meijering E et al.: In vivo characterization and quantifcation of atherosclerotic carotid plaque components with multidetector computed tomography and histopathological correlation. Arterioscler. Thromb. Vasc. Biol. 26(10), 2366-2372 (2006).
40. 18F- fuorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque infammation in patients. J. Am. Coll. Cardiol. 48(9), 1818-1824 (2006).
41. 18F fuorodeoxyglucose positron-emission tomography and high-resolution magnetic resonance imaging. Stroke 36(12), 2642-2647 (2005).
42. 18fuorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque infammation is highly reproducible: implications for atherosclerosis therapy trials. J. Am. Coll. Cardiol. 50(9), 892-896 (2007).
43. 18F-FDG-PET uptake and dynamic contrast enhanced MRI perfusion parameters in a rabbit model of atherosclerosis. Presented at: International Society of Magnetic Resonance in Medicine. Berlin, Germany, 19-25 May 2007
44. Hatsukami TS, Ross R, Polissar NL, Yuan C: Visualization of fbrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging. Circulation 102(9), 959-964 (2000).
45. Mitsumori LM, Hatsukami TS, Ferguson MS, Kerwin WS, Cai J, Yuan C: In vivo accuracy of multisequence MRI for identifying unstable fbrous caps in advanced human carotid plaques. J. Magn. Reson. Imaging 17(4), 410-420 (2003).
46. Trivedi RA, U-King-Im J, Graves MJ et al.: Multi-sequence in vivo MRI can quantify fbrous cap and lipid core components in human carotid atherosclerotic plaques. Eur. J. Vasc. Endovasc. Surg. 28(2), 207-213 (2004).
47. Trivedi RA, U-King-Im J, Graves MJ et al.: MRI-derived measurements of fbrous-cap and lipid-core thickness: the potential for identifying vulnerable carotid plaques in vivo. Neuroradiology 46(9), 738-743 (2004).
48. Cai J, Hatsukami TS, Ferguson MS et al.: In vivo quantitative measurement of intact fbrous cap and lipid-rich necrotic core size in atherosclerotic carotid plaque: comparison of high-resolution, contrast-enhanced magnetic resonance imaging and histology Circulation 112(22), 3437-3444 (2005).
49. Shinnar M, Fallon JT, Wehrli S et al.: The diagnostic accuracy of ex vivo MRI for human atherosclerotic plaque characterization. Arterioscler. Thromb. Vasc. Biol. 19(11), 2756-2761 (1999).
50. Wasserman BA, Smith WI, Trout HH 3rd, Cannon RO 3rd, Balaban RS, Arai AE: Carotid artery atherosclerosis: in vivo morphologic characterization with gadolinium-enhanced double-oblique MRI initial results. Radiology 223(2), 566-573 (2002).
51. Moody AR, Murphy RE, Morgan PS et al.: Characterization of complicated carotid plaque with magnetic resonance direct thrombus imaging in patients with cerebral ischemia. Circulation 107(24), 3047-3052 (2003).
52. Toussaint JF, Lamuraglia GM, Southern JF, Fuster V, Kantor HL: Magnetic resonance images lipid, fbrous, calcifed, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. Circulation 94(5), 932-938 (1996).
53. Fayad ZA, Fuster V: Characterization of atherosclerotic plaques by magnetic resonance imaging. Ann. NY Acad. Sci. 902, 173-186 (2000). (Pubitemid 30389122)
54. Saam T, Ferguson MS, Yarnykh VL et al.: Quantitative evaluation of carotid plaque composition by in vivo MRI. Arterioscler. Thromb. Vasc. Biol. 25(1), 234-239 (2005).
55. Kampschulte A, Ferguson MS, Kerwin WS et al.: Differentiation of intraplaque versus juxtaluminal hemorrhage/thrombus in advanced human carotid atherosclerotic lesions by in vivo magnetic resonance imaging. Circulation 110(20), 3239-3244 (2004).
56. Yuan C, Mitsumori LM, Ferguson MS et al.: In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques. Circulation 104(17), 2051-2056 (2001).
57. Takaya N, Cai J, Ferguson MS et al.: Intra-and interreader reproducibility of magnetic resonance imaging for quantifying the lipid-rich necrotic core is improved with gadolinium contrast enhancement. J. Magn. Reson. Imaging 24(1), 203-210 (2006).
58. Oppenheim C, Naggara O, Touze E et al.: High-resolution MRI of the cervical arterial wall: what the radiologist needs to know. Radiographics 29(5), 1413-1431 (2009).
59. Kerwin W, Hooker A, Spilker M et al.: Quantitative magnetic resonance imaging ana lysis of neovasculature volume in carotid atherosclerotic plaque. Circulation 107(6), 851-856 (2003).
60. Kerwin WS, O'Brien KD, Ferguson MS, Polissar N, Hatsukami TS, Yuan C: Infammation in carotid atherosclerotic plaque: a dynamic contrast-enhanced MRI study. Radiology 241(2), 459-468 (2006).
61. Hayes CE, Mathis CM, Yuan C: Surface coil phased arrays for high resolution imaging of the carotid arteries. J. Magn. Reson. Imaging 1, 109-112 (1996).
62. Fayad ZA, Fuster V: Clinical imaging of the high-risk or vulnerable atherosclerotic plaque. Circ. Res. 89(4), 305-316 (2001). (Pubitemid 34132668)
63. Chu B, Ferguson MS, Chen H et al.: Cardiac magnetic resonance features of the disruption-prone and the disrupted carotid plaque. JACC Cardiovasc. Imaging 2(7), 883-896 (2009).
64. Yuan C, Kerwin WS, Yarnykh VL et al.: MRI of atherosclerosis in clinical trials. NMR Biomed. 19(6), 636-654 (2006).
65. Saam T, Hatsukami TS, Takaya N et al.: The vulnerable, or high-risk, atherosclerotic plaque: noninvasive MRI for characterization and assessment. Radiology 244(1), 64-77 (2007).
66. Yuan C, Kerwin WS: MRI of atherosclerosis. J. Magn. Reson. Imaging 19(6), 710-719 (2004).
67. Fayad ZA, Fuster V, Fallon JT et al.: Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation 102(5), 506-510 (2000). (Pubitemid 30639967)
68. Chu B, Kampschulte A, Ferguson MS et al.: Hemorrhage in the atherosclerotic carotid plaque: a high-resolution MRI study. Stroke 35(5), 1079-1084 (2004).
69. Winternitz MC, Thomas RM, Le Compte PM: The Biology of Arterioscleriosis. CC Thomas, Springfeld, IL, USA (1938).
70. O'Brien KD, McDonald TO, Chait A, Allen MD, Alpers CE: Neovascular expression of e-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation 93, 672-682 (1996).
71. Galis ZS, Muszynski M, Sukhova GK et al.: Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ. Res. 75(1), 181-189 (1994).
72. Galis ZS, Sukhova GK, Lark MW, Libby P: Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94(6), 2493-2503 (1994).
73. Nikkari ST, O'Brien KD, Ferguson M et al.: Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. Circulation 92(6), 1393-1398 (1995).
74. Levy A P, Moreno PR: Intraplaque hemorrhage. Curr. Mol. Med. 6(5), 479-488 (2006).
75. Yuan C, Kerwin WS, Ferguson MS et al.: Contrast-enhanced high resolution MRI for atherosclerotic carotid artery tissue characterization. J. Magn. Reson. Imaging 15(1), 62-67 (2002).
76. Moreno PR, Purushothaman KR, Sirol M, Levy A P, Fuster V: Neovascularization in human atherosclerosis. Circulation 113(18), 2245-2252 (2006).
77. O'Brien KD, Allen MD, Mcdonald TO et al.: Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. J. Clin. Invest. 92(2), 945-951 (1993).
78. De Boer OJ, Van Der Wal AC, Teeling P, Becker AE: Leucocyte recruitment in rupture prone regions of lipid-rich plaques: a prominent role for neovascularization Cardiovasc. Res. 41(2), 443-449 (1999).
79. Moulton KS, Vakili K, Zurakowski D et al.: Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc. Natl Acad. Sci. USA 100(8), 4736-4741 (2003).
80. Celletti FL, Waugh JM, Amabile PG, Kao EY, Boroumand S, Dake MD: Inhibition of vascular endothelial growth factor-mediated neointima progression with angiostatin or paclitaxel. J. Vasc. Interv. Radiol. 13(7), 703-707 (2002).
81. Padhani AR: Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions. J. Magn. Reson. Imaging 16(4), 407-422 (2002).
82. 1-weighted MRI of a diffusable tracer: standardized quantities and symbols. J. Magn. Reson. Imaging 10(3), 223-232 (1999).
83. Barter PJ, Nicholls S, Rye KA, Anantharamaiah GM, Navab M, Fogelman AM: Anti-infammatory properties of HDL. Circ. Res. 95(8), 764-772 (2004).
84. Botti TP, Amin H, Hiltscher L, Wissler RW: A comparison of the quantitation of macrophage foam cell populations and the extent of apolipoprotein E deposition in developing atherosclerotic lesions in young people: high and low serum thiocyanate groups as an indication of smoking. PDAY Research Group. Pathobiological Determinants of Atherosclerosis in Youth. Atherosclerosis 124(2), 191-202 (1996).
85. Takaya N, Yuan C, Chu B et al.: Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events: a prospective assessment with MRI-initial results. Stroke 37(3), 818-823 (2006).
86. Singh N, Moody AR, Gladstone DJ et al.: Moderate carotid artery stenosis: MRI-depicted intraplaque hemorrhage predicts risk of cerebrovascular ischemic events in asymptomatic men. Radiology 252(2), 502-508 (2009).
87. Altaf N, Daniels L, Morgan PS et al.: Detection of intraplaque hemorrhage by magnetic resonance imaging in symptomatic patients with mild to moderate carotid stenosis predicts recurrent neurological events. J. Vasc. Surg. 47(2), 337-342 (2008).
88. Kolodgie FD, Gold HK, Burke AP et al.: Intraplaque hemorrhage and progression of coronary atheroma. N. Engl. J. Med. 349(24), 2316-2325 (2003).
89. Takaya N, Yuan C, Chu B et al.: Presence of intraplaque hemorrhage stimulates progression of carotid atherosclerotic plaques: a high-resolution magnetic resonance imaging study. Circulation 111(21), 2768-2775 (2005).
90. Underhill HR, Yuan C, Yarnykh VL et al.: Arterial remodeling in the subclinical carotid artery: a natural history study JACC (2009) (In Press).
91. Yuan C, Zhang SX, Polissar NL et al.: Identifcation of fbrous cap rupture with magnetic resonance imaging is highly associated with recent transient ischemic attack or stroke. Circulation 105(2), 181-185 (2002).
92. Underhill HR, Yuan C, Yarnykh VL et al.: Predictors of surface disruption with MRI in asymptomatic carotid artery stenosis. Am. J. Neuroradiol. (2009) (In Press).
93. Oikawa M, Kerwin W, Underhill H, Yuan C, Polissar N, Hatsukami T: Association between adventitial vaso vasorum and incident fbrous cap rupture: a prospective, longitudinal dynamic contrast-enhanced MRI study. Circulation 116(Suppl. II), 410 (2007).
94. Saam T, Underhill HR, Chu B et al.: Prevalence of American Heart Association type VI carotid atherosclerotic lesions identifed by magnetic resonance imaging for different levels of stenosis as measured by duplex ultrasound. J. Am. Coll. Cardiol. 51(10), 1014-1021 (2008).
95. Dong L, Hatsukami T, Ota H et al.: Magnetic resonance angiography measurement of carotid stenosis underestimates plaque burden identifed by magnetic resonance imaging. Circulation 118(18 Suppl. 2), S757-S758 (2008).
96. Dong L, Underhill HR, Yu W et al.: Geometric and compositional appearance of atheroma in an angiographically normal carotid artery in patients with atherosclerosis. AJNR Am. J. Neuroradiol. (2009) (Epub ahead of print).
97. Briley-Saebo KC, Mulder WJ, Mani V et al.: Magnetic resonance imaging of vulnerable atherosclerotic plaques: current imaging strategies and molecular imaging probes. J. Magn. Reson. Imaging 26(3), 460-479 (2007).
98. Briley-Saebo KC, Shaw PX, Mulder WJ et al.: Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specifc epitopes. Circulation 117(25), 3206-3215 (2008).
99. Amirbekian V, Lipinski MJ, Briley-Saebo KC et al.: Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI. Proc. Natl Acad. Sci. USA 104(3), 961-966 (2007).
100. Chen W, Vucic E, Leupold E et al.: Incorporation of an apoE-derived lipopeptide in high-density lipoprotein MRI contrast agents for enhanced imaging of macrophages in atherosclerosis. Contrast Media Mol. Imaging 3(6), 233-242 (2008).
101. Sanz J, Fayad ZA: Imaging of atherosclerotic cardiovascular disease. Nature 451(7181), 953-957 (2008).